$ABIO News After-hours trades still risky, a dec
Post# of 44956
Posted On: 01/13/2014 11:50:00 AM
$ABIO News
After-hours trades still risky, a decade later 2:23 p.m. June 9, 2011 - Kate Gibson
Monday's biggest gaining and declining stocks 3:20 p.m. May 17, 2010 - MarketWatch
MDRNA, ARCA move on patent office updates 1:08 p.m. March 29, 2010 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 3:36 p.m. March 26, 2010 - MarketWatch
ARCA Bio surges 226% on patent 2:22 p.m. March 26, 2010 - Shawn Langlois
ARCA Biopharma shares surge 220% to $8.56 2:02 p.m. March 26, 2010 - Laura Mandaro
Monday's biggest gaining and declining stocks 3:43 p.m. June 1, 2009 - MarketWatch
Arca Biopharma: A Genetically Targeted Drug For Atrial Fibrillation In Heart Failure Patients 3:53 p.m. Jan. 10, 2014 - Seeking Alpha
FDA accepts test to be used in ARCA Biopharma trial 9:16 a.m. Jan. 8, 2014 - Seeking Alpha
Morning Market Movers 8:59 a.m. Jan. 8, 2014 - benzinga.com
ARCA Biopharma Announces FDA Acceptance of Gencaro Companion Diagnostic Test IDE 7:32 a.m. Jan. 8, 2014 - benzinga.com
FDA Clears ARCA Bio To Start Landmark Personalized Medicine Clinical Trial 10:10 a.m. Dec. 4, 2013 - Seeking Alpha
OCLS – Why Oculus Jumped Over 145% Today 8:27 a.m. Dec. 4, 2013 - InvestorPlace.com
10-Q: ARCA BIOPHARMA, INC. 4:41 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
ARCA Biopharma Announces Clinical Trial Agreement for GENETIC-AF Trial 7:35 a.m. Nov. 6, 2013 - benzinga.com
Refined And Ready To Rebound: We Like What We See At Arca Bio 8:00 a.m. Sept. 9, 2013 - Seeking Alpha
Arca Biopharma Prepares For A Second Life 4:52 p.m. Aug. 21, 2013 - Seeking Alpha
ARCA biopharma Provides Business Update 6:32 a.m. July 17, 2013 - benzinga.com
Stocks Hitting 52-Week Lows 8:23 a.m. June 13, 2013 - benzinga.com
ARCA biopharma Announces Closing of $20M Equity Offering 6:06 a.m. June 5, 2013 - benzinga.com
Afternoon Market Losers 12:31 p.m. May 30, 2013 - benzinga.com
10-Q: ARCA BIOPHARMA, INC. 4:25 p.m. May 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Market Close: Big Winners & Losers for April 23, 2013 2:51 p.m. April 23, 2013 - 247WallSt.com
Biogen Idec, Celgene And AbbVie Move To New Highs 4:24 p.m. April 22, 2013 - Investors Business Daily
Market Close: Big Winners & Losers for April 22, 2013 2:58 p.m. April 22, 2013 - 247WallSt.com
ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM 6:02 a.m. April 22, 2013 - benzinga.com
10-K: ARCA BIOPHARMA, INC. 4:23 p.m. March 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Today - PR Newswire - PRF
ARCA biopharma Announces US FDA Acceptance of Gencaro Companion Diagnostic Test IDE 8:30 a.m. Jan. 8, 2014 - BusinessWire
ARCA biopharma to Present at Biotech Showcase 2014 8:30 a.m. Jan. 7, 2014 - BusinessWire
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Stocks Outperformed the Broader Markets: Facebook Inc, Twitter Inc, CF Industries Holdings, Green Mountain Coffee Roasters, Arca Biopharma 9:18 a.m. Dec. 5, 2013 - PR Newswire
ARCA biopharma Announces IDE Submission to US FDA for Gencaro Companion Diagnostic Test 8:30 a.m. Dec. 5, 2013 - BusinessWire
TrendingWallStreet.com Releases Coverage on OCLS, EXPR, ABIO, and VTMB 12:21 a.m. Dec. 5, 2013 - ACCESSWIRE
ARCA biopharma Announces US FDA Acceptance of Gencaro IND Application for the Treatment of Atrial Fibrillation 8:30 a.m. Dec. 4, 2013 - BusinessWire
ARCA biopharma Announces Resignation from Board of Directors 5:00 p.m. Nov. 21, 2013 - BusinessWire
ARCA biopharma Announces Clinical Trial Agreement for GENETIC-AF Trial 8:30 a.m. Nov. 6, 2013 - BusinessWire
VOLC, GLUU, ABIO and EROC added to NASDAQ Active Stock Watch List at EPR 9:18 a.m. Oct. 29, 2013 - ACCESSWIRE
ARCA biopharma Announces IND Submission to US FDA for Gencaro for the Treatment of Atrial Fibrillation 7:00 a.m. Oct. 29, 2013 - BusinessWire
Exclusive Video Interviews With CEOs Now on Equities.com: ABIO, INO, IVX, NETD, OPXA 7:00 a.m. Sept. 25, 2013 - GlobeNewswire
Robert E. Conway Appointed to ARCA biopharma Board of Directors 7:30 a.m. Sept. 4, 2013 - BusinessWire
ARCA biopharma to Present at the Rodman & Renshaw Annual Global Investment Conference 7:30 a.m. Aug. 21, 2013 - BusinessWire
Raymond L. Woosley, M.D., Ph.D. Appointed to ARCA biopharma Board of Directors 7:30 a.m. July 30, 2013 - BusinessWire
ARCA biopharma Announces Steering Committee for GENETIC-AF Trial 7:30 a.m. July 24, 2013 - BusinessWire
ARCA biopharma Announces Additions to GENETIC-AF Leadership Team 7:30 a.m. July 22, 2013 - BusinessWire
ARCA biopharma Provides Business Update 7:30 a.m. July 17, 2013 - BusinessWire
Gencaro(TM) Potential Efficacy in Preventing Atrial Fibrillation Paper Published in JACC: Heart Failure 7:00 a.m. June 6, 2013 - BusinessWire
After-hours trades still risky, a decade later 2:23 p.m. June 9, 2011 - Kate Gibson
Monday's biggest gaining and declining stocks 3:20 p.m. May 17, 2010 - MarketWatch
MDRNA, ARCA move on patent office updates 1:08 p.m. March 29, 2010 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 3:36 p.m. March 26, 2010 - MarketWatch
ARCA Bio surges 226% on patent 2:22 p.m. March 26, 2010 - Shawn Langlois
ARCA Biopharma shares surge 220% to $8.56 2:02 p.m. March 26, 2010 - Laura Mandaro
Monday's biggest gaining and declining stocks 3:43 p.m. June 1, 2009 - MarketWatch
Arca Biopharma: A Genetically Targeted Drug For Atrial Fibrillation In Heart Failure Patients 3:53 p.m. Jan. 10, 2014 - Seeking Alpha
FDA accepts test to be used in ARCA Biopharma trial 9:16 a.m. Jan. 8, 2014 - Seeking Alpha
Morning Market Movers 8:59 a.m. Jan. 8, 2014 - benzinga.com
ARCA Biopharma Announces FDA Acceptance of Gencaro Companion Diagnostic Test IDE 7:32 a.m. Jan. 8, 2014 - benzinga.com
FDA Clears ARCA Bio To Start Landmark Personalized Medicine Clinical Trial 10:10 a.m. Dec. 4, 2013 - Seeking Alpha
OCLS – Why Oculus Jumped Over 145% Today 8:27 a.m. Dec. 4, 2013 - InvestorPlace.com
10-Q: ARCA BIOPHARMA, INC. 4:41 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
ARCA Biopharma Announces Clinical Trial Agreement for GENETIC-AF Trial 7:35 a.m. Nov. 6, 2013 - benzinga.com
Refined And Ready To Rebound: We Like What We See At Arca Bio 8:00 a.m. Sept. 9, 2013 - Seeking Alpha
Arca Biopharma Prepares For A Second Life 4:52 p.m. Aug. 21, 2013 - Seeking Alpha
ARCA biopharma Provides Business Update 6:32 a.m. July 17, 2013 - benzinga.com
Stocks Hitting 52-Week Lows 8:23 a.m. June 13, 2013 - benzinga.com
ARCA biopharma Announces Closing of $20M Equity Offering 6:06 a.m. June 5, 2013 - benzinga.com
Afternoon Market Losers 12:31 p.m. May 30, 2013 - benzinga.com
10-Q: ARCA BIOPHARMA, INC. 4:25 p.m. May 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Market Close: Big Winners & Losers for April 23, 2013 2:51 p.m. April 23, 2013 - 247WallSt.com
Biogen Idec, Celgene And AbbVie Move To New Highs 4:24 p.m. April 22, 2013 - Investors Business Daily
Market Close: Big Winners & Losers for April 22, 2013 2:58 p.m. April 22, 2013 - 247WallSt.com
ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM 6:02 a.m. April 22, 2013 - benzinga.com
10-K: ARCA BIOPHARMA, INC. 4:23 p.m. March 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Today - PR Newswire - PRF
ARCA biopharma Announces US FDA Acceptance of Gencaro Companion Diagnostic Test IDE 8:30 a.m. Jan. 8, 2014 - BusinessWire
ARCA biopharma to Present at Biotech Showcase 2014 8:30 a.m. Jan. 7, 2014 - BusinessWire
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Stocks Outperformed the Broader Markets: Facebook Inc, Twitter Inc, CF Industries Holdings, Green Mountain Coffee Roasters, Arca Biopharma 9:18 a.m. Dec. 5, 2013 - PR Newswire
ARCA biopharma Announces IDE Submission to US FDA for Gencaro Companion Diagnostic Test 8:30 a.m. Dec. 5, 2013 - BusinessWire
TrendingWallStreet.com Releases Coverage on OCLS, EXPR, ABIO, and VTMB 12:21 a.m. Dec. 5, 2013 - ACCESSWIRE
ARCA biopharma Announces US FDA Acceptance of Gencaro IND Application for the Treatment of Atrial Fibrillation 8:30 a.m. Dec. 4, 2013 - BusinessWire
ARCA biopharma Announces Resignation from Board of Directors 5:00 p.m. Nov. 21, 2013 - BusinessWire
ARCA biopharma Announces Clinical Trial Agreement for GENETIC-AF Trial 8:30 a.m. Nov. 6, 2013 - BusinessWire
VOLC, GLUU, ABIO and EROC added to NASDAQ Active Stock Watch List at EPR 9:18 a.m. Oct. 29, 2013 - ACCESSWIRE
ARCA biopharma Announces IND Submission to US FDA for Gencaro for the Treatment of Atrial Fibrillation 7:00 a.m. Oct. 29, 2013 - BusinessWire
Exclusive Video Interviews With CEOs Now on Equities.com: ABIO, INO, IVX, NETD, OPXA 7:00 a.m. Sept. 25, 2013 - GlobeNewswire
Robert E. Conway Appointed to ARCA biopharma Board of Directors 7:30 a.m. Sept. 4, 2013 - BusinessWire
ARCA biopharma to Present at the Rodman & Renshaw Annual Global Investment Conference 7:30 a.m. Aug. 21, 2013 - BusinessWire
Raymond L. Woosley, M.D., Ph.D. Appointed to ARCA biopharma Board of Directors 7:30 a.m. July 30, 2013 - BusinessWire
ARCA biopharma Announces Steering Committee for GENETIC-AF Trial 7:30 a.m. July 24, 2013 - BusinessWire
ARCA biopharma Announces Additions to GENETIC-AF Leadership Team 7:30 a.m. July 22, 2013 - BusinessWire
ARCA biopharma Provides Business Update 7:30 a.m. July 17, 2013 - BusinessWire
Gencaro(TM) Potential Efficacy in Preventing Atrial Fibrillation Paper Published in JACC: Heart Failure 7:00 a.m. June 6, 2013 - BusinessWire
(0)
(0)